File Download

There are no files associated with this item.

Supplementary

Conference Paper: Garadacimab for hereditary angioedema prophylaxis: Long-term efficacy and safety from the VANGUARD Phase 3b open-label extension trial (first interim analysis)

TitleGaradacimab for hereditary angioedema prophylaxis: Long-term efficacy and safety from the VANGUARD Phase 3b open-label extension trial (first interim analysis)
Authors
Issue Date2023
Citation
13th C1-inhibitor Deficiency & Angioedema Workshop How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/326528

 

DC FieldValueLanguage
dc.contributor.authorResehf, A-
dc.contributor.authorMargerl, M-
dc.contributor.authorMartinez-Saguer, I-
dc.contributor.authorBernstein, JA-
dc.contributor.authorFarkas, H-
dc.contributor.authorYang, WH-
dc.contributor.authorJacobs, JS-
dc.contributor.authorLi, PH-
dc.contributor.authorLumry, WR-
dc.contributor.authorAygoren-Pursun, E-
dc.contributor.authorOhsawa, I-
dc.contributor.authorKateralis, C-
dc.contributor.authorLonghurst, H-
dc.contributor.authorHakl, R-
dc.contributor.authorGuilarte, M-
dc.contributor.authorStroes, ESG-
dc.contributor.authorChen, YH-
dc.contributor.authorFeuersenger, H-
dc.contributor.authorBica, A-
dc.contributor.authorJacobs, I-
dc.contributor.authorCraig, TJ-
dc.date.accessioned2023-03-20T09:15:11Z-
dc.date.available2023-03-20T09:15:11Z-
dc.date.issued2023-
dc.identifier.citation13th C1-inhibitor Deficiency & Angioedema Workshop-
dc.identifier.urihttp://hdl.handle.net/10722/326528-
dc.languageeng-
dc.relation.ispartof13th C1-inhibitor Deficiency & Angioedema Workshop-
dc.titleGaradacimab for hereditary angioedema prophylaxis: Long-term efficacy and safety from the VANGUARD Phase 3b open-label extension trial (first interim analysis)-
dc.typeConference_Paper-
dc.identifier.emailLi, PH: liphilip@hku.hk-
dc.identifier.authorityLi, PH=rp02669-
dc.identifier.hkuros344521-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats